Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
201 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS | 20719 |
1356 | 1 | CANCER TESTIS ANTIGEN//NY ESO 1//MAGE | 2711 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CANCER TESTIS ANTIGEN | authKW | 2050775 | 10% | 67% | 264 |
2 | NY ESO 1 | authKW | 795729 | 4% | 68% | 101 |
3 | MAGE | authKW | 682601 | 3% | 65% | 91 |
4 | NEW YORK BRANCH | address | 566372 | 4% | 43% | 113 |
5 | CELLULAR GENET UNIT | address | 395228 | 2% | 51% | 67 |
6 | PRAME | authKW | 339974 | 1% | 75% | 39 |
7 | TUMOR ANTIGEN | authKW | 299841 | 5% | 19% | 135 |
8 | MAGE A | authKW | 269063 | 1% | 93% | 25 |
9 | GAGE | authKW | 246283 | 1% | 76% | 28 |
10 | LUDWIG CANC | address | 215396 | 10% | 7% | 265 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 26941 | 52% | 0% | 1400 |
2 | Immunology | 12017 | 32% | 0% | 877 |
3 | Medicine, Research & Experimental | 3459 | 14% | 0% | 388 |
4 | Pathology | 368 | 4% | 0% | 106 |
5 | Hematology | 249 | 4% | 0% | 101 |
6 | Cell Biology | 192 | 6% | 0% | 174 |
7 | Dermatology | 159 | 2% | 0% | 64 |
8 | Biotechnology & Applied Microbiology | 119 | 4% | 0% | 118 |
9 | Genetics & Heredity | 112 | 4% | 0% | 113 |
10 | Biochemical Research Methods | 42 | 2% | 0% | 63 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NEW YORK BRANCH | 566372 | 4% | 43% | 113 |
2 | CELLULAR GENET UNIT | 395228 | 2% | 51% | 67 |
3 | LUDWIG CANC | 215396 | 10% | 7% | 265 |
4 | CLIN ONCOIMMUNOL | 192878 | 2% | 37% | 45 |
5 | SURG BRANCH | 175483 | 5% | 12% | 127 |
6 | LAUSANNE BRANCH | 167452 | 3% | 18% | 78 |
7 | BRUSSELS BRANCH | 131045 | 2% | 21% | 53 |
8 | HUMAN IMMUNE THER Y | 125643 | 1% | 54% | 20 |
9 | LUDWIG CLIN TRIAL | 93759 | 0% | 73% | 11 |
10 | KLIN POLIKLIN ONKOL | 58591 | 0% | 46% | 11 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOTHERAPY | 58788 | 3% | 5% | 93 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 41459 | 5% | 3% | 126 |
3 | INTERNATIONAL JOURNAL OF CANCER | 23679 | 8% | 1% | 205 |
4 | CLINICAL CANCER RESEARCH | 9394 | 4% | 1% | 112 |
5 | CANCER RESEARCH | 6374 | 5% | 0% | 149 |
6 | JOURNAL OF IMMUNOLOGY | 5653 | 6% | 0% | 165 |
7 | JOURNAL OF EXPERIMENTAL MEDICINE | 3506 | 2% | 1% | 62 |
8 | CANCER IMMUNOLOGY RESEARCH | 2742 | 0% | 2% | 11 |
9 | MELANOMA RESEARCH | 2266 | 1% | 1% | 19 |
10 | CURRENT OPINION IN IMMUNOLOGY | 1972 | 1% | 1% | 22 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANCER TESTIS ANTIGEN | 2050775 | 10% | 67% | 264 | Search CANCER+TESTIS+ANTIGEN | Search CANCER+TESTIS+ANTIGEN |
2 | NY ESO 1 | 795729 | 4% | 68% | 101 | Search NY+ESO+1 | Search NY+ESO+1 |
3 | MAGE | 682601 | 3% | 65% | 91 | Search MAGE | Search MAGE |
4 | PRAME | 339974 | 1% | 75% | 39 | Search PRAME | Search PRAME |
5 | TUMOR ANTIGEN | 299841 | 5% | 19% | 135 | Search TUMOR+ANTIGEN | Search TUMOR+ANTIGEN |
6 | MAGE A | 269063 | 1% | 93% | 25 | Search MAGE+A | Search MAGE+A |
7 | GAGE | 246283 | 1% | 76% | 28 | Search GAGE | Search GAGE |
8 | SEREX | 214620 | 2% | 38% | 49 | Search SEREX | Search SEREX |
9 | MAGE A3 | 201735 | 1% | 64% | 27 | Search MAGE+A3 | Search MAGE+A3 |
10 | MAGE 1 | 163735 | 1% | 78% | 18 | Search MAGE+1 | Search MAGE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |